FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

323119000: Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3500630013 Carbidopa 12.5 mg and levodopa 50 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3677288013 Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet est un(e) (attribut) Product containing only carbidopa and levodopa in oral dose form (medicinal product form) false Inferred relationship Some
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet est un(e) (attribut) Co-careldopa (product) false Inferred relationship Some
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) Carbidopa false Inferred relationship Some
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet a une forme pharmaceutique (attribut) comprimé false Inferred relationship Some
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) Levodopa (substance) false Inferred relationship Some
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet est un(e) (attribut) Product containing carbidopa and levodopa (medicinal product) false Inferred relationship Some
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet a une forme pharmaceutique (attribut) Oral tablet false Inferred relationship Some
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet est un(e) (attribut) Product manufactured as oral dose form (product) false Inferred relationship Some
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet est un(e) (attribut) Product containing carbidopa and levodopa in oral dose form (medicinal product form) false Inferred relationship Some
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) Levodopa (substance) false Inferred relationship Some 1
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Levodopa (substance) false Inferred relationship Some 1
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has presentation strength numerator value (attribute) 50 (qualifier value) false Inferred relationship Some 1
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) false Inferred relationship Some 1
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has presentation strength denominator value un false Inferred relationship Some 1
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Some 1
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) Carbidopa false Inferred relationship Some 2
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Carbidopa false Inferred relationship Some 2
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has presentation strength numerator value (attribute) 12.5 (qualifier value) false Inferred relationship Some 2
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) false Inferred relationship Some 2
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has presentation strength denominator value un false Inferred relationship Some 2
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Some 2
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Carbidopa false Inferred relationship Some 1
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has presentation strength numerator value (attribute) 12.5 (qualifier value) false Inferred relationship Some 1
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Levodopa (substance) false Inferred relationship Some 2
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has presentation strength numerator value (attribute) 50 (qualifier value) false Inferred relationship Some 2
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has unit of presentation Tablet (unit of presentation) false Inferred relationship Some
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has precise active ingredient Carbidopa false Inferred relationship Some 1
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has precise active ingredient Levodopa (substance) false Inferred relationship Some 2
    Carbidopa 12.5 mg and levodopa 50 mg oral tablet Count of base of active ingredient deux false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start